In a recent article on The Genetic Link, we talked about going global and how our regulatory strategy helps support our customers who are conducting genetic research. Today, I am focusing on the work we do to ensure our products' compatibility with the technologies our genetic research and testing customers use in the field and in their labs.
DNA Genotek's Sample Collection Blog
We always enjoy hearing about how our customers are using our products for innovative projects. Recently, we learned about a new project in Germany called GeneTalk, which uses Oragene to collect DNA from saliva. GeneTalk is what many physicians and scientists working on human next generation sequencing (NGS) data sets have been waiting for. We know that NGS is an effective method for identifying rare disease causing variants associated with genetic disorders and as a valuable tool for diagnosing and treating many other diseases. The challenge in analyzing the sequence variants of a patient is to discriminate between all the variants without medical relevance and the mutations that actually have an impact on the disease. Many believe that a large database of exomes from healthy controls may help to create this benchmark and thus speed up the identification of the mutations causing genetic disorders. This is where GeneTalk comes in.
We are very excited to tell you about a new award from DNA Genotek. Today, we introduced the GenoFIND Genomic Services Award, which is designed to facilitate analysis of nucleic acid samples. The award will accelerate genetic discoveries by providing $10,000 US in GenoFIND services to the selected winner. GenoFIND is a compilation of commercially available genomic services that include: nucleic acid extraction, SNP genotyping, PCR-based assays, whole genome and targeted sequencing, array-based SNP and expression profiling, custom assay development and bioinformatic analysis.
DNA from Oragene/saliva samples continues to gain acceptance as a suitable sample input for next generation sequencing technologies (NGS) from targeted to exome to whole genome sequencing. The latest development in this body of evidence is the recent announcement by Complete Genomics that they will now accept DNA from Oragene/saliva samples for whole genome sequencing.